BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33455918)

  • 1. Arg206Cys substitution in
    Coke LN; Wen H; Comeau M; Ghanem MH; Shih A; Metz CN; Li W; Langefeld CD; Gregersen PK; Simpfendorfer KR
    Ann Rheum Dis; 2021 Jun; 80(6):782-787. PubMed ID: 33455918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the DNASE1L3 rs35677470 polymorphism with systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis: Structural biological insights.
    Zervou MI; Andreou A; Matalliotakis M; Spandidos DA; Goulielmos GN; Eliopoulos EE
    Mol Med Rep; 2020 Dec; 22(6):4492-4498. PubMed ID: 33173951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.
    Zochling J; Newell F; Charlesworth JC; Leo P; Stankovich J; Cortes A; Zhou Y; Stevens W; Sahhar J; Roddy J; Nash P; Tymms K; Rischmueller M; Lester S; Proudman S; Brown MA
    Arthritis Res Ther; 2014 Oct; 16(5):438. PubMed ID: 25332064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6.
    Oparina NY; Delgado-Vega AM; Martinez-Bueno M; Magro-Checa C; Fernández C; Castro RO; Pons-Estel BA; D'Alfonso S; Sebastiani GD; Witte T; Lauwerys BR; Endreffy E; Kovács L; Escudero A; López-Pedrera C; Vasconcelos C; da Silva BM; Frostegård J; Truedsson L; Martin J; Raya E; Ortego-Centeno N; de Los Angeles Aguirre M; de Ramón Garrido E; Palma MJ; Alarcon-Riquelme ME; Kozyrev SV
    Ann Rheum Dis; 2015 Mar; 74(3):e14. PubMed ID: 24534757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Impaired DNASE1L3 Activity to Anti-DNA Autoantibody Production in Systemic Lupus Erythematosus.
    Mathapathi S; Chu CQ
    Rheumatol Immunol Res; 2022 Mar; 3(1):17-22. PubMed ID: 36467024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dnase1l3 deficiency in lupus-prone MRL and NZB/W F1 mice.
    Wilber A; O'Connor TP; Lu ML; Karimi A; Schneider MC
    Clin Exp Immunol; 2003 Oct; 134(1):46-52. PubMed ID: 12974753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum level of DNase1l3 in patients with dermatomyositis/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity.
    Zhao Q; Yang C; Wang J; Li Y; Yang P
    Clin Exp Med; 2017 Nov; 17(4):459-465. PubMed ID: 28039554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus.
    Carbonella A; Mancano G; Gremese E; Alkuraya FS; Patel N; Gurrieri F; Ferraccioli G
    Lupus; 2017 Jun; 26(7):768-772. PubMed ID: 27821515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus.
    Al-Mayouf SM; Sunker A; Abdwani R; Abrawi SA; Almurshedi F; Alhashmi N; Al Sonbul A; Sewairi W; Qari A; Abdallah E; Al-Owain M; Al Motywee S; Al-Rayes H; Hashem M; Khalak H; Al-Jebali L; Alkuraya FS
    Nat Genet; 2011 Oct; 43(12):1186-8. PubMed ID: 22019780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A monogenic lupus family caused by homozygous deletions of DNASE1L3 gene and literature review].
    Wang W; Li XL; Li WD; Ou JB; Gao SH; Zhang CH; Liu YL; Sun ZC; Ma MS; Song HM
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1276-1281. PubMed ID: 36444430
    [No Abstract]   [Full Text] [Related]  

  • 11. Deficiency of macrophage-derived Dnase1L3 causes lupus-like phenotypes in mice.
    Engavale M; Hernandez CJ; Infante A; LeRoith T; Radovan E; Evans L; Villarreal J; Reilly CM; Sutton RB; Keyel PA
    J Leukoc Biol; 2023 Nov; 114(6):547-556. PubMed ID: 37804110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus.
    Korn MA; Steffensen M; Brandl C; Royzman D; Daniel C; Winkler TH; Nitschke L
    Front Immunol; 2023; 14():1095830. PubMed ID: 36969253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus.
    Wu CJ; Guo J; Luo HC; Wei CD; Wang CF; Lan Y; Wei YS
    Rheumatol Int; 2016 Jan; 36(1):45-52. PubMed ID: 26289938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A haplotype confers susceptibility to systemic lupus erythematosus but not to rheumatoid arthritis in Mexican patients.
    Montúfar-Robles I; Barbosa-Cobos RE; Alemán-Ávila I; Ramírez-Bello J
    Int J Rheum Dis; 2019 Mar; 22(3):473-479. PubMed ID: 30398030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus.
    Cherian TS; Kariuki SN; Franek BS; Buyon JP; Clancy RM; Niewold TB
    Arthritis Rheum; 2012 Oct; 64(10):3383-7. PubMed ID: 22674082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis.
    Bruschi M; Bonanni A; Petretto A; Vaglio A; Pratesi F; Santucci L; Migliorini P; Bertelli R; Galetti M; Belletti S; Cavagna L; Moroni G; Franceschini F; Fredi M; Pazzola G; Allegri L; Sinico RA; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Ramoino P; Bianchini P; Puppo F; Pupo F; Negrini S; Mattana F; Emmi G; Garibotto G; Santoro D; Scolari F; Ravelli A; Tincani A; Cravedi P; Volpi S; Candiano G; Ghiggeri GM
    J Rheumatol; 2020 Mar; 47(3):377-386. PubMed ID: 31092713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the folate metabolizing enzymes: Association with SLE susceptibility and in silico analysis.
    Salimi S; Keshavarzi F; Mohammadpour-Gharehbagh A; Moodi M; Mousavi M; Karimian M; Sandoughi M
    Gene; 2017 Dec; 637():161-172. PubMed ID: 28943344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
    Fathi F; Sadeghi E; Lotfi N; Hafezi H; Ahmadi M; Mozafarpoor S; Motedayyen H
    Int J Immunogenet; 2020 Feb; 47(1):57-64. PubMed ID: 31565862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin-3A,
    Liu LN; Wang P; Zou YF; Xu Z; Cheng J; Zhang Y; Hu W; Pan HF
    Autoimmunity; 2019 Jun; 52(4):161-167. PubMed ID: 31394943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.